Oral Answers to Questions

Debate between Mark Harper and Matt Hancock

Thursday 16th May 2024 Commons Chamber

[Mr Harper]

I will say a couple of things. First, the hon. Lady called for action. My hon. Friend the roads Minister has already been meeting the industry and Treasury Ministers, who are responsible for the industry regulator, so we are already doing that. As I said, this is an issue not just in the UK but elsewhere.

Secondly, as I said, the hon. Lady said in her letter that she was looking at outlawing the ability for insurers to price according to risk in local areas. I am sure that hon. Members noticed that she has not denied that, so they will know that she is proposing for people across the country to face higher costs to reflect the higher crime that we see in inner London, where her Labour Mayor has failed to get a grip.

[Matt Hancock (West Suffolk) (Ind)]

T5. Will the Rail Minister join me in campaigning to save Brandon station, which is a beautiful listed building that has been out of use for years? Greater Anglia, to its credit, is trying to find a solution to ensure that that beautiful building can be put back into use. Will he join me in that campaign and, if his diary allows, join me on 14 June, when we have a public meeting to drive that forward?

Coronavirus

Debate between Mark Harper and Matt Hancock

Wednesday 16th June 2021 Commons Chamber

[Matt Hancock]

I bring to the House these regulations to change the date of implementation of step 4 of the Government’s road map. On 8 December last year, we fired the starting gun on the race between the vaccine and the virus and started delivering a programme that has allowed us to restore so many of the precious freedoms that we cherish. In the space of just six months, we have now given first doses of coronavirus vaccines to almost four in five adults in the UK, and we have given second doses to over 30 million people. We have made such rapid progress through the cohorts that, today, we are able to extend the offer of a vaccine to anyone aged 21 and over.

Thanks to the protection of the vaccination programme, huge advances in treatments like dexamethasone, which was discovered a year ago today, and the resolve of the British people in following the rules that this House has laid down, we have been able to take the first three steps on our road map, removing restrictions and restoring colour to the nation, but we have always said that we would take each step at a time and look at the data and our four tests before deciding whether to proceed. The regulations before the House today put into effect our decision to pause step 4 on our roadmap until 19 July. Before outlining the regulations that will put this into effect, I would like to set out why we made this difficult but essential decision.

Unfortunately, there has been a significant change since we started on our journey down the road map in February. A new variant has given the virus extra legs, both because it spreads more easily and because there is some evidence that the risk of hospitalisation is higher than for the alpha variant, which was, of course, previously dominant in this country. The delta variant now accounts for 96% of new cases. The number of cases is rising and hospitalisations are starting to rise, too—they are up 48% over the past week. The number of deaths in England is thankfully not rising and remains very low, but, as I told the House on Monday, we do not yet know the extent to which the link between hospitalisations and deaths has been broken, so we propose to give the NHS a few more crucial weeks to get those remaining jabs into the arms of those who need them.

Although we are taking the steps outlined in the regulations today, and I know this is disappointing for many people, we know that science has given us a solution. We must use this time to protect as many people as we can as quickly as we can, because even though the vaccination programme has been going at a blistering pace, there are still people who we must protect.

[Mr Mark Harper (Forest of Dean) (Con)]

Can I just ask my right hon. Friend what we expect to achieve in the four weeks? I think I am right in saying that there are 1.3 million people in priority groups one to nine who have yet to have a second dose of the vaccination. The good point is that that means we have vaccinated 96% of people in those groups, but I just wonder—after four weeks, I doubt that we will get to 100%, so there will still be a significant number of people in those groups not vaccinated with two doses, and at that point, there is still going to be some risk. My worry, and the worry of others, is that we are going to get to this point in four weeks’ time and we will just be back here all over again extending the restrictions. That is what we are concerned about.

[Matt Hancock]

No—on the contrary, that is our view of how far through the vaccination programme we need to get. We are not aiming to eradicate the virus in this country because that is not possible. Indeed, in the parts of the country where it has been tried, it has been found to be not possible. We are aiming to live with this virus like we do with flu. I can give my right hon. Friend an update: as of midnight last night, 1.2 million over-50s and 4.4 million over-40s have had their first jab, but not their second. We seek to get a second jab into a majority—not all, but a majority—of them by 19 July. The estimate is that by taking that pause in this step, we can save thousands of lives. I can tell my right hon. Friend that taking further time and pausing for longer is not estimated to save many more lives, because of the level of protection especially among the over-50s, who are, as we all know, the most likely to die from this disease.

--- Later in debate ---

[Matt Hancock]

No, I do not agree with mandatory vaccination of the public, but for those who have a duty to care, in an environment that includes some of the most vulnerable people in the country, I think this is a sensible and reasonable step in order to save lives.

[Mr Harper]

The Secretary of State will also be aware that staff who provide domiciliary care in people’s homes—they potentially provide care to many people, going to many homes during the day—are also caring and present a similar challenge. It would be preferable, in the first instance, if we could get those vaccination rates up by education and persuasion. I am prepared, if that is not possible, and following the precedent we have in the NHS for those who perform operations and have to be vaccinated against hepatitis, to agree to this matter, but there is a real issue here with the millions of people who provide domiciliary care, who are often employed directly. How is that going to work and provide the level of protection required?

[Matt Hancock]

Yes, we do propose to consult on this point, alongside the consultation on mandatory vaccination as a condition of deployment in the NHS. As my right hon. Friend rightly says, this is a complicated operational matter. The principle of vaccination for those in a caring responsibility is already embedded, as he says; there is a history going back more than a century of vaccination being required in certain circumstances. I think these are reasonable circumstances, so we will go ahead for those who work in care homes and we will consult about those in domiciliary care and those working in the NHS. However, I have no proposals for going, and would not expect us to go, any wider.

Covid-19 Update

Debate between Mark Harper and Matt Hancock

Monday 14th June 2021 Commons Chamber

[Mr Mark Harper (Forest of Dean) (Con)]

Before I ask the Secretary of State my question, I should just say—as a former Government Chief Whip, it does not give me any great pleasure to do so—that I wholly associate myself with your remarks earlier, Mr Speaker. This statement should have been made to this House by the Prime Minister before it was made to the media. I hope that we do not see a recurrence of it and I wish you well in your meeting with him.

The Secretary of State has set out that it is not the Government’s policy to get to zero covid—indeed, that is not possible. Can he say whether it is the Government’s policy to maintain a low prevalence of this virus? If it is not, can he confirm the Prime Minister’s sentiments today that 19 July is a terminus date, and can he rule out bringing back restrictions in the autumn and winter when we see an inevitable rise in what is a respiratory virus?

[Matt Hancock]

Well, it is not inevitable—I do not think it is inevitable. It may happen, but it is not inevitable because we also have the planned booster programme to strengthen further the vaccination response. But it is absolutely clear, based on all the clinical advice that I have seen, that a goal of eradication of this virus is impossible. Indeed, there is one part of this country that tried it for a bit in the summer and found it to be impossible. Therefore, we must learn to live with this virus and we must learn how we can live our normal lives with this virus, so I reflect the Prime Minister’s words, which, of course, I concur with entirely, on 19 July. Our goal is to make sure that we get as much vaccination done between now and then—especially those second doses—to make sure that we can open up safely, even if there is a rise in cases, by protecting people from hospitalisation and especially from dying of this awful disease.

Oral Answers to Questions

Debate between Mark Harper and Matt Hancock

Tuesday 8th June 2021 Commons Chamber

[Mr Mark Harper (Forest of Dean) (Con)]

Mr Speaker, I am very grateful that you could fit me in at the end.

Yesterday during the statement the Secretary of State did not have the information to hand on the efficacy of the covid vaccines in reducing serious disease and hospitalisation. He made a commitment, rightly, to set them out today at Health questions at the Dispatch Box; and I am delighted, with this question, to give him the opportunity to do so.

[Matt Hancock]

First, I can say that a single dose of the Pfizer or AstraZeneca jab offers protection of 75% to 85% against hospitalisation, while data on two doses, which is currently available only for Pfizer, indicates 90% to 95% effectiveness against hospitalisation and 95% to 99% effectiveness at preventing death. However, my right hon. Friend also asked specifically about the delta variant, and I said that I did not have the figure in my head for the reduction in hospitalisations. I do not know whether I should be glad, but I can report to him that the reason is that there is not yet a conclusive figure. This morning I spoke to Dr Mary Ramsay, who runs this research at Public Health England, and she told me that the figure is currently being worked on. The analysis is being done scientifically and should be available in the coming couple of weeks. This is obviously an absolutely critical figure and I will report it to the House as soon as we have it.

Covid-19 Update

Debate between Mark Harper and Matt Hancock

Monday 7th June 2021 Commons Chamber

[Matt Hancock]

We are doing work in this area and talking to all the relevant bodies. Aside from some who have not yet understood the full importance of high-quality usage of data in the health system, actually, the vast majority of people, including the BMA, the Royal College of GPs and others, can see the benefit of getting this right. So we are working with them. The goal, though, is really clear—to use data better in the NHS because data saves lives.

[Mr Mark Harper (Forest of Dean) (Con)]

The Secretary of State laid out a number of decisions that will be announced next Monday, and the most significant of those will be on social distancing. If that remains, whatever else changes, we will not have gone anywhere close to back to normal. However, can I press him a bit on vaccine efficacy? The SNP spokesman, the hon. Member for Central Ayrshire (Dr Whitford), said that the first dose was only 30% effective. I believe that that is correct for transmission, but as for what is actually important, which is reducing serious disease and hospitalisation, the first dose is significantly more effective than that. Will the Secretary of State set out to the House his and the Department’s current understanding about the efficacy of the vaccine on the first dose and the second dose against serious disease and hospitalisation?

[Matt Hancock]

My right hon. Friend is absolutely right about the figure for transmissibility reduction from the first dose. The figures for the reduction in serious disease and death are, as he says, higher than that, but since I do not have the precise figures in my head, what I propose to do is set them out tomorrow at the Dispatch Box at Health questions.

Covid-19: Government Handling and Preparedness

Debate between Mark Harper and Matt Hancock

Thursday 27th May 2021 Commons Chamber

[Matt Hancock]

It has been an incredibly difficult time for those who have worked in and lived in care homes throughout this pandemic. That has been true across the world, and I pay tribute to the staff in social care who have done so much. It was, of course, a difficult challenge, especially at the start when many characteristics of this virus were unknown. As I have answered many times in this House, we have published full details of the approach that we are taking and that we have taken. We have worked with the care home sector as much as possible to keep people safe and followed the clinical advice on the appropriate way forward.

[Mr Mark Harper (Forest of Dean) (Con)]

May I take the Secretary of State back to what he said in his statement about the B1617.2 variant first discovered in India, which I think will be of the most concern to my constituents and the country in the days and weeks ahead? We are bound to see an increase in cases as we open up; that is inevitable. The important thing is breaking that link between cases, hospitalisations and deaths. My understanding of all the current evidence is that our vaccines are very effective in stopping serious disease, including from that B1617.2 variant. If that remains the case, does he agree that, on 15 June, there would be no reason not to go ahead with opening up fully on 21 June? That is the important question to which we need an answer.

[Matt Hancock]

That is literally the most important question to which we do not yet have a full answer. The data that we have suggest that, in the hotspot areas, around one in 10 of those in hospital are people who have had both jabs. That is a function both of the protection that we get from the vaccine against this variant and also of the age profile of those who are catching the disease. Those who have not been vaccinated include those who are old enough to have been offered the jab and those who have not yet been offered the jab. The fact that 90% of the people in hospital are those who have not yet been double vaccinated gives us a high degree of confidence that the vaccine is highly effective, but the fact that 10% of people in hospital have been double vaccinated shows that the vaccine is not 100% effective. We already knew that, but we are better able to calibrate as we see these data. We will learn more about this over the forthcoming week or two before we make and publish an assessment ahead of 14 June about what the data are saying about taking the step that is pencilled in for not before 21 June.

Covid-19 Update

Debate between Mark Harper and Matt Hancock

Monday 17th May 2021 Commons Chamber

[Matt Hancock]

It is really clear that we are removing restrictions. I am delighted that we are able to remove restrictions, such as the absolute restrictions on close physical contact, and rely more on people’s personal responsibility. In order to do that, we are providing the best possible advice that we can, such as to hug, but cautiously. Everybody knows what that means: it means outside is better than inside, it means making sure it is in ventilated spaces and it means that those who have had the vaccine, and in particular two vaccines, are safer than those who have not.

It is incumbent on us all to communicate these messages from our scientists and to make sure that people understand them. I am pretty sure that the British public get that. Given how brilliantly people have responded to requests during the pandemic, I am highly confident that this approach will be successful and that people will be cautious, but enjoy the new freedoms that we are thankfully able to give.

[Mr Mark Harper (Forest of Dean) (Con)]

I listened very carefully to what the Secretary of State said in his statement about people being able to prove that they have had the vaccination through the NHS app. I also listened carefully to what he said about the importance of the Union. Can I just draw to his attention something that I hope he can look at urgently? I have thousands of constituents who live in England, but who are registered with GPs in Wales and who receive their vaccinations in Wales. At the moment, it is not proving possible for them to register with the NHS app that they have had their vaccination. Can I ask him to urgently fix that for my constituents and those across our United Kingdom?

[Matt Hancock]

This is another example of where we work better together as one United Kingdom; we are working to solve this problem precisely. Coming from the borders with Wales, I understand this very clearly. Work is under way to ensure that there is interoperability between the data systems in England, Wales, Scotland and Northern Ireland. This situation was not foreseen when health responsibilities were devolved. I have been working with my counterparts in the three devolved nations on fixing it, and we have agreed to fix it. Getting these data to talk to each other is technically complicated, but that work is under way.

Covid-19 Update

Debate between Mark Harper and Matt Hancock

Monday 19th April 2021 Commons Chamber

[Matt Hancock]

We keep all these decisions for each country under constant review. The challenge of the genomic data is that some countries have excellent coverage of genomic sequencing and others do not. Actually, that is not particularly correlated with their income. For instance, South Africa, a middle-income country, has excellent genomic sequencing. We take the decisions very rapidly when we need to. We keep all this under constant review and I am glad that she welcomes the decision to put India on the red list today.

[Mr Mark Harper (Forest of Dean) (Con)]

May I add my congratulations to all those who have been involved in the fantastic vaccine roll-out that the Secretary of State set out in his statement? It is obviously breaking the link between cases, hospitalisations and deaths, as we are seeing dramatically from the figures. Many members of the public and businesses, having looked at the road map, which he also mentioned, will have seen that as of 21 June, the Government and the public are expecting the country to be broadly back to normal, but, of course, there is the small print about the reviews on social distancing. Will he confirm to the House and the public that as of 21 June, he expects us to be broadly back to normal, without social distancing? If that is not the case, will he set out what the evidence base will be for that decision?

[Matt Hancock]

Any decisions like that would be based on the evidence, and we have far more evidence now than we did when making these decisions previously. I fully expect that there will be some areas of life, without the need for laws in this place, where people will behave more cautiously than previously. The wearing of masks is one—before this pandemic, wearing a mask in public in this country was extremely unusual. I imagine that some people will wear masks, and choose to wear masks, for some time to come. Our goal is to manage this virus and the pandemic that it has caused more like flu—in fact, like flu. Flu comes through each year. We do take action to deal with flu—we take action on nosocomial infection in hospitals and through the flu vaccine programme—but we do not stop normal life as we know it. That is the overall attitude and approach. My right hon. Friend mentions that four reviews were set out as part of the road map and they will, of course, have to conclude. But that is my hope because, as he knows, I very firmly believe that this vaccine is breaking that link. We can see it in the data every single day and in the way that the country is responding. It is uplifting.

Coronavirus

Debate between Mark Harper and Matt Hancock

Thursday 25th March 2021 Commons Chamber

[Matt Hancock]

Over the past year, we have all been engaged in a monumental national effort to fight coronavirus, which has required the House to take extraordinary measures in response to this extraordinary threat. Today, we debate our road map to recovery and what is legally needed to take the cautious but irreversible path out of this pandemic. We propose to remove some of the emergency powers that the House put in place a year ago and set the steps of the road map that my right hon. Friend the Prime Minister has set out into law, replacing the existing national lockdown. We are able to take this action and propose these measures thanks to the perseverance of the British people in following the rules and the success story that is our UK vaccination programme, which has now vaccinated more than 28.6 million people—55% of all adults in the United Kingdom.

Hospitalisations are now at their lowest point since September and are down 90% since the peak. To put this into context, there are today just over 5,000 people in hospital with covid. At the peak, just two months ago, there were just under 5,000 new admissions with covid each day. Deaths are now at their lowest point since October and they are down 94% since the peak. The research published today shows that our vaccination programme has already saved the lives of more than 6,000 people across the UK, up to the end of February.

The success of the vaccination programme means that we are now able to carefully replace the short-term protection of the restrictions that we have all endured, with the long-term protection provided by the vaccine. Our goal is to be cautious yet irreversible. I must tell the House, Madam Deputy Speaker, that while I am still, by nature, an optimist, there remain causes for caution. Cases are rising in some areas and they are rising among those under 18. There are early signs of cases flattening among the working-age population, too.

I am delighted that uptake of the vaccine is now 95% among over-60s and that protection against dying from the vaccine is around 85%. Both of those figures, 95% uptake and 85% protection, are higher than we could have hoped for, but while we are confident that we have broken the link between the number of cases and the hospitalisations and deaths that previously inevitably followed, no vaccine is perfect and take-up is not 100%, so that link, while broken, is not yet severed.

New variants also remain a risk because we do not yet know with confidence the impact of the vaccine against the new variants. We all want these next few months to be a one-way route to freedom, so as we restore the freedoms that we all cherish, we must do so in a way that does not put our NHS at risk.

[Mr Mark Harper (Forest of Dean) (Con)]

On that point about the take-up and the efficacy, one thing that the chief medical officer said was that the timings in the road map were driven by some of the modelling that the Government had seen. The assumptions behind that modelling I think came from February and are much more pessimistic than what we now know about take-up and efficacy. Can the Secretary of State ensure that that modelling is redone with the new assumptions to see whether that would justify a faster unlocking of the country, which is important to save jobs, save businesses and maximise the economic future of our young people?

[Matt Hancock]

While modelling is obviously something that is looked at, the observation of the actual data is I think the best guide. The good news is that the number of deaths has fallen very sharply and continues to fall sharply, and the number of hospitalisations has fallen sharply—not quite as sharply as deaths, but nevertheless sharply. Critically, the link has broken, so the weight that we place on the number of cases as an indicator is not nearly as great as it was before, because it used to be inevitable that that led to hospitalisations and deaths.

The reason for the timings in the road map is so that, after each step, we can see its impact before being able, carefully, to take the next step. That is the core reason for the timings in the road map—four weeks to see the impact of a step, and then one week to give warning of the next step. It is that, rather than the modelling, that I put the stress on for the timings in the road map.

[Mr Harper]

To come back very briefly on that final point, if deaths and hospitalisations are what is important, is the Secretary of State able to confirm the information that was published in The Times this morning on the modelling by SPI-M—the Scientific Pandemic Influenza Group on Modelling, the Government’s advisory committee —showing a dramatic reduction in hospitalisations and deaths taking place over the next week and throughout April? That really drives my assumption that we could go a bit faster. Is he able to confirm that for the House?

[Matt Hancock]

I have not seen that article in The Times—I have read parts of The Times, but not that bit—so I cannot confirm, but I can write to my right hon. Friend with details on this point. However, I would stress that the focus only on modelling is not really where the ultimate judgment on the timings of the road map is; it is about being able to observe progress and then take the next step with confidence. The central point here is that cases may well rise. In fact, I would say cases are likely to rise, not least with schools going back. The critical thing is that the automaticity—cases going up having an impact on hospitalisations—is no longer there. However, if cases got extremely high, even with a much weaker link from cases to hospitalisations, that is something we clearly have to guard against and it is set out in test 3 of the Prime Minister’s four tests.

--- Later in debate ---

[Matt Hancock]

Yes, that is an important point. We have just started the process of working on that. If measures have worked well and we want to keep them because they are good, can we put them permanently on the statute book? That should, properly, take the process of normal primary legislation. My hon. Friend mentions a forthcoming health and care Bill. I look to the Leader of the House and I can see that he is smiling, although I cannot, of course, say whether that Bill will be brought forward until we have a proper sign-off—it is nice to see him looking so handsome there. [Laughter.]Our aim would be to get that on to the statute book, should we bring it forward, in the middle of next year, so there is a shorter-term question of the handling from here to there. We need to do that with the best administrative efficiency that we can, but I am talking here about the less controversial elements of the Act.

[Mr Harper]

I am grateful for the Secretary of State’s judgment and I will try not to test his patience again. He mentioned that there are some very valuable administrative measures. If they were the only things being rolled forward, I do not think people would mind, although my reading of the Act is that the registration provisions for medical staff are in section 89, in the permanent part of the Act rather than the temporary part. The controversial parts include the police powers to detain potentially infectious persons, which the hon. Member for Twickenham (Munira Wilson) referred to, and which have been used unlawfully on a number of occasions. It says in the one-year review of the Act that those are intended to be long-term powers and my right hon. Friend has just suggested that those provisions might be rolled forward a further six months. That is why so many of us are worried. These are extraordinary provisions, not for normal times, and they should be expired at the earliest possible opportunity.

[Matt Hancock]

I actually agree with my right hon. Friend that they should be expired at the earliest possible opportunity. The challenge, especially as we lift measures on all of us, is if there are, for instance, new variants that we need to pin down absolutely—in the same way that a new variant came about in Liverpool and we tackled it. We have not seen any new cases of it, not only because of fantastic local work, but because in lockdown that is easier. Having these very targeted interventions for now is important. Therefore, we have made the judgment that we should propose that they are necessary for now. I know that we disagree on that point, but I suggest that by voting against all these renewals, a whole load of valuable things that he and I would agree on would not be renewed, were that vote to go through.

Covid-19 Update

Debate between Mark Harper and Matt Hancock

Tuesday 9th February 2021 Commons Chamber

[Matt Hancock]

I do not say this lightly, but I agree with every single word that the right hon. Lady said. I want to pay tribute to her, because I have not had the chance in the House to thank all the black MPs who took part in the incredibly moving video to persuade people, who may have understandable concerns, that taking the jab is the right thing to do. She played a pivotal role in that short video, and it is just one small part of the huge effort we need to make, because the fewer people who do not have the protection, the safer we will all be. I am very grateful for her work and her support, and I hope that we can continue to work together to drive uptake among black communities right across this country.

[Mr Mark Harper (Forest of Dean) (Con)]

Policies are often easy to announce and difficult to end. The chief scientific adviser says that covid is with us forever, and it will presumably continue to mutate into new variants forever. I listened carefully to the answer that the Secretary of State gave to my hon. Friend the Member for Bexhill and Battle (Huw Merriman), but I did not hear an answer to this: when is this policy going to end, if ever, because if the virus continues to mutate, surely the risk will be there forever?

[Matt Hancock]

The risk of mutations absolutely can and will be managed through the evolution of vaccines, in the way that the annual flu jab changes each year and allows us to protect ourselves. While necessary now, these are not measures that can be in place permanently. We need to replace them over time with a system of safe and free international travel; that is where we need to get to. The first task is to vaccinate the population. If we get good news on the impact of vaccination on hospitalisations and deaths for new mutations, we will be in a better place. If we do not get such good news, we will need to use the updated vaccines to protect against the variants of concern.

The scientists inform and advise me that there are, repeatedly and independently around the world, mutations of the same type in the E484K area of the virus, as mentioned by the hon. Member for Leicester South (Jonathan Ashworth). That gives the scientists a good start in where to target the new updated vaccine—if we have to wait until then—but it may be that we get from the existing vaccines enough efficacy against hospitalisation and death that they work perfectly well to hold this virus down. We just do not know that yet; hence, the precautionary principle applies.

Covid-19 Update

Debate between Mark Harper and Matt Hancock

Tuesday 2nd February 2021 Commons Chamber

[Matt Hancock]

We have put a significant amount of extra funding into supporting children’s mental health alongside adult mental health. We know that one of the consequences of the lockdown, which is absolutely necessary, is that it puts significant pressure on mental health services. We have seen the increased burden on those services, and it is very important that people get the support they need.

[Mr Mark Harper (Forest of Dean) (Con)]

May I add my congratulations to those who have been rolling out the vaccine? I listened carefully to what my hon. Friend the Member for Kettering (Mr Hollobone) said, and I want to put on record my thanks to those in Gloucestershire, which, as of last Thursday, was the top performing part of the country. Hereford and Worcestershire next door was the second highest performing part, which kind of makes them the highest-performing roll-outs in the whole of the western world. I thank the Secretary of State for his help and that fantastic performance.

I want to take the Secretary of State back to his answer to my hon. Friend the Member for Winchester (Steve Brine). The whole point of the vaccine roll-out is to ensure that we protect the vulnerable, reduce the death toll and reduce hospitalisations and the pressure on the health service. Given that the vaccine roll-out is going so well and is, I suspect, ahead of where the Secretary of State thought it would be, will he confirm that when schools start going back on 8 March, it will be those two metrics falling—deaths and hospitalisations—that will guide the reopening of not just schools but the rest of the economy?

[Matt Hancock]

The Prime Minister has set out four metrics that we will follow. Deaths and hospitalisations are two of them, and they are both incredibly important. We expect deaths to fall faster than hospitalisations, because older people who are higher up in the JCVI cohorts are more likely to die by a greater degree than they are more likely to use hospital beds. The other two considerations are that we do not see further new variants that put all this at risk and, of course, that the vaccination programme rolls out well. I would not say that the vaccination programme is ahead of plans. I would say that it is on track; I make no further claim than that.

Public Health

Debate between Mark Harper and Matt Hancock

Wednesday 6th January 2021 Commons Chamber

[Matt Hancock]

Yes, it is very much part of the plan; it is happening right now. On mutations and the link to the vaccine, as with flu, where mutations mean we have to change the vaccine each year, any vaccine might have to be updated in the future, but that is not our understanding of the situation now. Of course that is being double-checked and tested, both with the scientists at Porton Down and, as we roll out the vaccine in areas where there is a high degree of the new variant, and by the pharmacological surveillance of those who have been vaccinated, which will allow us to see for real the impact of the vaccine on the new variant. The goal, as my right hon. Friend the Prime Minister said, is that by the middle of next month we plan to have offered the first dose to everyone in the top four priority groups, and they currently account for four out of five covid fatalities. I am not sure that this point has fully been addressed, but the strong correlation between age and fatality from covid means we will be able to vaccinate those who account for four out of every five fatalities within the top four cohorts. It does then take two to three weeks from the first dose to reach immunity, but the vaccine is therefore the way out of this pandemic and the way to a better year ahead.

[Mr Mark Harper (Forest of Dean) (Con)]

Will my right hon. Friend give way?

--- Later in debate ---

[Matt Hancock]

Yes, but then I want to make some progress on the detail of the regulations.

[Mr Harper]

I am grateful; it is on the specific point that my right hon. Friend has raised. He knows I understand it, because it is exactly the one I raised with him in this House last week when we were recalled, and I welcomed the Prime Minister’s commitment to it. To go back to the question from my hon. Friend the Member for Winchester (Steve Brine), my right hon. Friend is clear that once we have vaccinated those four groups and they have got immunity, we have therefore taken care of 80% of the risk of death. So what possible reason is there at that point for not rapidly relaxing the restrictions in place on the rest of our country?

[Matt Hancock]

We have to see the impact of that vaccination on the reduction in the number of deaths, which I very much hope we will see at that point. That is why we will take an evidence-led move down through the tiers when—I hope—we have broken the link between cases and hospitalisations and deaths. We will need to see the protection in lived reality on the ground, but we will watch this like a hawk. My aim is to keep these restrictions in place for not a moment longer than they are necessary.

--- Later in debate ---

[Matt Hancock]

I can assure my hon. Friend that the agreed schedule of delivery will enable us to offer vaccinations to everyone in the top four priority groups by the middle of February. That is why the Prime Minister was able to commit us to that schedule.

I want to talk about the support that has been outlined. We are providing an additional £4.6 billion of support to businesses, including those in retail, hospitality and leisure that have been forced to close their doors once again, on top of the £280 billion plan for jobs, which includes the extension of the furlough scheme until April.

[Mr Harper]

I will be brief—I do not want to try your patience, Madam Deputy Speaker. My hon. Friend the Member for Winchester (Steve Brine) raised his point because earlier this week we had a fantastic call with our hon. Friend the Minister for Patient Safety, Suicide Prevention and Mental Health, who is responsible for vaccine delivery, in which we asked a number of times about the agreed schedule but did not get a clear answer. If it has been agreed with the companies, why can my right hon. Friend not just publish it, so that we know when the vaccine will arrive? That will give people confidence that we will deliver on the Prime Minister’s commitment to the country.

[Matt Hancock]

I will happily take that point away, but I can tell my right hon. Friend that that supply allows for delivery on the schedule and the target the Prime Minister set, to which my whole team is working.

Covid-19 Update

Debate between Mark Harper and Matt Hancock

Wednesday 30th December 2020 Commons Chamber

[Matt Hancock]

Yes, there is of course support for the testing of schoolchildren, and I am sure that my right hon Friend the Education Secretary will be happy to set out more details in his statement shortly. The support of the armed forces, especially from those who have experience of the mass testing roll-out so far, will be incredibly helpful, but it is not the only thing that will help the roll-out of mass testing in schools. I am really grateful to the schools that have been involved so far for the enthusiasm that they have shown and for the extra effort they have put into making this work. I look forward to seeing that happen across much more of the country.

[Mr Mark Harper (Forest of Dean) (Con)]

The Secretary of State, with his announcement, has effectively locked down most of England. In a previous interview with Andrew Marr, he said we will effectively be staying in that place until the vaccines are rolled out.

On this morning’s excellent news about the AstraZeneca vaccine, the chief executive of that company said that it could produce up to 2 million doses a week if the Government’s ambitious schedule for rolling it out could match that. Will the Secretary of State match it so we can get everyone over 65, which is nearly 90% of those at risk of death and hospitalisation, done in seven weeks, by the third week of February, and we can then remove these restrictions? Every focus of the Government now has to be on that task. It is the central, overriding task of government. Are the Government up to doing it?

[Matt Hancock]

I am absolutely delighted to be able to agree with every single word that my right hon. Friend says. He and I have not always agreed on every dot and cross of the policy on how to handle this pandemic but, regarding how we get out of it from here, it sounds like we are aligned on needing to roll out this vaccine as fast as possible.

The NHS can deliver at the pace my right hon. Friend mentions if we can get the manufacturing up to that speed. Of course, we are working with AstraZeneca to make that happen. I was on the radio at the same time as the chief executive this morning, and I was delighted to hear his commitments. AstraZeneca has worked so hard to make this happen and, crucially, we have to protect the most vulnerable. The fact that only one dose is needed to give protection is incredibly helpful, and that way we can get rid of these blasted restrictions as soon as possible.

Covid-19 Update

Debate between Mark Harper and Matt Hancock

Thursday 17th December 2020 Commons Chamber

[Matt Hancock]

The hon. Lady raises an incredibly important point. It does not matter whether or not somebody is registered with anybody, they can still spread the disease. The reason for the answer that she was given is that we have to try to get the vaccination programme out to everybody, no matter their status. There are people who do not have any status in paperwork at all, and we need to make sure that we support the roll-out to them as well. We are working with the Ministry of Housing, Communities and Local Government, which is best placed, along with local authorities, to make sure that the vaccination programme reaches anybody who fulfils the criteria set out by the Joint Committee on Vaccination and Immunisation.

[Mr Mark Harper (Forest of Dean) (Con)]

I welcome the fact that Gloucestershire is remaining in tier 2 and thank the Secretary of State for his engagement with me and my Gloucestershire colleagues this week—it was very much appreciated and it was very much a team effort to get to where we are. May I press him a little on what he said about vaccines? Will he confirm that the data that is going to be published from next week will have enough detail in it that we will be able to see clearly the vaccination roll-out by age and by area? Will he set out, early on when we return in January, the Government’s thinking about how far the vaccination programme needs to have gone and the level of risk that we will have reduced for the country such that we can start to release the restrictions that are so burdensome on our population?

[Matt Hancock]

Yes. We are committed to setting out weekly updates on the vaccination programme—we released the first data yesterday, on the 137,000 number—and increasingly with the sorts of breakdowns that my right hon. Friend asks for, as more and more groups are reached. He asked for the calculus in terms of the proportion of the population that needs to be protected in order that we are able to bring down restrictions, and that is exactly how we are thinking about the next phase. We do not yet know the impact of the vaccine on transmission, so we cannot yet have a concrete answer to his question, but it is precisely the question that we are asking. We should know much more within the next few weeks.

Covid-19 Vaccine Roll-out

Debate between Mark Harper and Matt Hancock

Tuesday 8th December 2020 Commons Chamber

[Matt Hancock]

Of course I will defend to the end the work that we did to get the PPE roll-out to which the hon. Lady refers. Of course we had priority contracts, because we wanted, when somebody had a good lead, to be able to see if we could make an arrangement as fast as possible, but that was all done through the proper processes, as the NAO report sets out. She asks—I have a lot of respect for the hon. Lady, but really—whether private companies will be involved in the vaccine roll-out. Try Pfizer or BioNTech, the people who came up with and are manufacturing this vaccine. Without them, we would not have a vaccine at all, and a bit of a thank you would do well from the Chair of the Public Accounts Committee.

[Mr Mark Harper (Forest of Dean) (Con)]

I join the Secretary of State in thanking the NHS staff in my Gloucestershire Hospitals NHS Foundation Trust who are in the first 50 hospitals to be rolling out the vaccine. That is very welcome, including to my constituents. Given that he was right to be a little cautious about the speed at which we will be able to get this vaccine rolled out, it seems to me not right that we should keep every single restriction in place until we have rolled out the vaccine to the entire population. The onus still remains on the Government to justify every restriction and the balance between the benefits of reducing covid, the economic impact and the non-covid health harm. May I ask the Government to set out that detail before the House is asked to take another decision on these restrictions in January?

[Matt Hancock]

The House might be relieved to know that my right hon. Friend and I agree with each other on the need to ensure that, as the vaccine is rolled out to vulnerable groups, we monitor the impact of the vaccine on reducing cases, reducing hospitalisations and reducing the number of people who sadly die from this disease, and take that basis for the judgment of how soon we can lift the restrictions. He and I want to lift the restrictions as soon as is safely possible, and the question of the judgment on how safely is one that we will have to monitor and debate in this House over the coming weeks and months.

Covid-19

Debate between Mark Harper and Matt Hancock

Monday 2nd November 2020 Commons Chamber

[Matt Hancock]

The hon. Gentleman invites me to get involved in political controversy in Wales while rejecting the principle of getting involved in political controversy. Having thought about it, on balance, I am going to sidestep that particular political controversy. As it happens, I strongly think that the public expect us to work together in the national interest, and that is what we propose to do.

A crucial part of that national interest is protecting the most vulnerable. When coronavirus spreads rapidly, it reaches all parts. Many of the most vulnerable can live only with care and support from those outside their home, or live in multigenerational households. We must protect the most vulnerable from the disease, and we will, with renewed shielding advice and support for care homes, but we cannot rely on that alone.

There is no quick fix to this pandemic; there is no silver bullet. What makes this fight so tough is that the virus thrives on all the things that make life worth living, such as the joy of social contact and the communal events that give us so much happiness and fulfilment, but we must persevere together to get it under control.

[Mr Mark Harper (Forest of Dean) (Con)]

One of the key things that we will depend on after the lockdown is over—assuming that the House gives its support—is a really effective contact tracing system. The Secretary of State knows as well as I do that, in the last couple of weeks, the system has been reaching only 48% of the contacts of those who have tested positive. The Scientific Advisory Group for Emergencies says that for the system to be effective, it needs to reach 80%. In the 28 days of lockdown, what specific steps will he take to get it to 80%?

[Matt Hancock]

My right hon Friend is right; I was going to come on to that issue. Of course the contact tracing system needs to contact as many people as it can. The figures that he refers to include a huge array of different types of contact. I will update the House on the improvements that we have seen in contact tracing, including an increase in the absolute number of people who have been contacted and in the proportion.

We absolutely need the proportion to go up. A critical part of that is people’s engagement with the contact tracing system, as well as the system itself. Some of the proportion who are not reached are not reached because their contact details are not given. It is quite hard to blame the people who work in NHS Test and Trace, who are working so hard on it, for that particular reason. It is important to go into the details of why a particular contact is not made and try to improve all those details. That work is ongoing, but I accept the challenge.

Public Health: Coronavirus Regulations

Debate between Mark Harper and Matt Hancock

Tuesday 13th October 2020 Commons Chamber

[Matt Hancock]

The SAGE advice that Ministers receive is, of course, published; we have had great debates in this House about that and it is published. We make decisions that are guided by the science, taking into account all the different considerations we need to look to.

[Mr Mark Harper (Forest of Dean) (Con)]

It is worth giving credit to the NHS Test and Trace team for the growth in testing, but the evidence published yesterday said that the impact of the testing and tracing system was having only a marginal effect on reducing the virus. So can the Secretary of State look not just in high-risk areas, but in all areas to get more of the contact tracing done by our fantastic directors of public health and their teams?

[Matt Hancock]

Yes, absolutely. We are doing precisely that. The way it works where it works best is that the big national system makes the immediate and rapid contact with people who test positive—for more than half of people that is immediately successful—and then when contacts are harder to make the data is passed to the local teams, which do not have the scale to do the immediate, rapid contacting but do have the boots on the ground and the local knowledge. That combination of the two is what works best where it works well.

Coronavirus Act 2020 (Review of Temporary Provisions)

Debate between Mark Harper and Matt Hancock

Wednesday 30th September 2020 Commons Chamber

[Matt Hancock]

Yes. What I have said relates to measures to do with the pandemic response. As my hon. Friend says, the vast majority of the measures in respect of social distancing restrictions were introduced under 1984 Act; only a minority were introduced under the Coronavirus Act. Nevertheless, the point about scrutiny is an important one no matter what the origin of the statutory instrument. In essence, we have managed to innovate with parliamentary procedure to find a way that we can move both quickly and with the proper scrutiny of Parliament. That is what we have been seeking to do. In these unprecedented circumstances, many innovations have had to be made, not least in Parliament, and this is another one. There were two contrasting needs—the need for proper scrutiny and the need for very speedy action—and I am really pleased that we have been able to find a way through that, I hope, commands the support of the whole House.

[Mr Mark Harper (Forest of Dean) (Con)]

I thank my right hon. Friend and the business managers for the work they have done in reaching this solution, and I hope, Mr Speaker, that you will think that, following your stern words earlier, the Government have listened and come forward with some measures that have responded appropriately.

May I just press the Secretary of State? He said in his remarks that the Government will bring forward votes in advance of the measures coming into force on national measures covering the whole of England or the whole of the UK. Obviously, some of the measures that have come into force so far have been quite significant, covering large parts of the country and millions of people. I accept there is a judgment to be made here; can he say a little more about where the line will be drawn about what is brought to this House in advance?

[Matt Hancock]

In a way my right hon. Friend, who has huge experience in these matters, answers his own question, because of course there is a judgment to be made. We have made a very clear commitment to the process that we will follow, and I hope that over the weeks to come we will demonstrate through our actions and through what we bring forward that we are true to that commitment, which essentially will become a new convention.

Covid-19

Debate between Mark Harper and Matt Hancock

Monday 28th September 2020 Commons Chamber

[Matt Hancock]

That includes some brilliant interventions from my right hon. Friend, who calls for more from a sedentary position. So there is further work to do, and I look forward to engaging with colleagues to ensure that we have the proper parliamentary scrutiny.

[Mr Mark Harper (Forest of Dean) (Con)]

To develop the point made by my right hon. Friend the Member for Gainsborough (Sir Edward Leigh), I accept the points about scrutiny that the Secretary of State makes, but it is about not just scrutiny but the laws we are making. The laws that came in at midnight, for example, were 12 pages of laws, with lots of detail, criminal offences and duties not mentioned when they were set out in a statement last week. That includes duties on employers, directors and officers, with serious criminal penalties. We need to scrutinise the detail of the legislation before it comes into force and give our assent, and not, I am afraid, just allow the Secretary of State to put it into force by decree.

[Matt Hancock]

Of course, sometimes in this pandemic we have to move fast. Sometimes we have had to move fast, and we may need to do so again. The challenge we have in this House is how to ensure proper scrutiny while also being able, when necessary, to move fast in response to the virus. That is the challenge that collectively we all face.

--- Later in debate ---

[Matt Hancock]

We always look at the effects of these policies. We have to take everything in the round, including the level of social distancing that might have been going on, were that to continue all through the night. One reason we brought in the policy is that we have seen it work in other countries, as the hon. Lady knows. None of these interventions on social distancing are ones that we take lightly or want to put in place. The central question is how we keep control of the virus in the best possible way, while reducing the impact on the economy and on education as much as possible.

[Mr Harper]

I am grateful to the Secretary of State for his indulgence in taking a second intervention. I agree with him: unlike some people, I think we need to take tough measures to deal with the virus, and that we sometimes need to act quickly. The really important question is: will the measures be effective, and do we have the evidence to support that? Therefore, I gently say to the Secretary of State that that is why I think that Ministers coming to Parliament, marshalling the arguments and laying out the evidence, means that we get better decisions that are likely to be more effective in dealing with the virus and protecting our economy. I think that is the general view of many colleagues, on both sides of the House, and I hope he will reflect on that when he meets my hon. Friend the Member for Altrincham and Sale West (Sir Graham Brady).

[Matt Hancock]

It is a view that I very largely share. In fact, I would go so far as to say that the number of times that I have stood at this Dispatch Box and taken into account points made by Members, from either side of the House, is beyond what I can count. Listening to points that have been made has been part of the rhythm of the response. I therefore caution against the idea that there has not been parliamentary scrutiny, and I know that because I have been at this Dispatch Box usually several times a week when Parliament has been sitting. But I understand the concerns—of course I do—and I hope we can find an appropriate way forward.

Covid-19 Update

Debate between Mark Harper and Matt Hancock

Tuesday 8th September 2020 Commons Chamber

[Matt Hancock]

We are absolutely putting more resources into that local end of the contact tracing, but I stress that it is one system. I think the right hon. Gentleman has made the same category error as the hon. Member for Leicester South (Jonathan Ashworth). If we count contact tracing results from institutional settings within the local categorisation, of course the number of contacts that we reach is higher—for instance, in a care home it is very easy to reach 100% of contacts, by the nature of the setting. The hon. Member for Leicester South, who is also a very sensible fellow, tried to make that comparison, and it is not quite fair—it is not comparing apples with apples.

[Mr Mark Harper (Forest of Dean) (Con)]

The Secretary of State is right to warn against complacency, and perhaps it would be wise to remind people that we are in this for the long haul. My I ask him a question about testing? The director of testing for NHS Test and Trace has confirmed that we have testing capacity at all our testing sites, but that there is a critical pinch point in the laboratories. My director of public health, who is excellent, and a number of her colleagues in the south-west would prefer that, rather than artificially limiting access to testing sites and home testing kits, we ensured that people could take those tests locally and managed the pinch point at the laboratory end of things, because that would improve public confidence in getting testing. Is that something that my right hon. Friend could take away and look at? If he cannot do that, can he at least give me a good reason that I can take back to her about why that is not possible?

[Matt Hancock]

I entirely understand the point, and I can see the argument that is being made. The challenge is, since lab capacity is what we need more of, that if we take more swabs locally and send them in to the lab, we need to have the lab capacity to be able to turn them round. Otherwise, we get a much slower response, which means that we are not getting back to people fast enough for them to be able to act. That is the nature of the challenge, and the answer is more lab capacity, which is what we are driving through.

Covid-19 Update

Debate between Mark Harper and Matt Hancock

Tuesday 24th March 2020 Commons Chamber

[Matt Hancock]

Yes, it is acceptable. It is right that volunteers in that sort of work, for example Samaritans, should travel to do it.

[Mr Mark Harper (Forest of Dean) (Con)]

The Secretary of State will know that, following the Prime Minister’s statement yesterday, all tourism and leisure providers have closed. I commend those in my constituency that closed before the advice was given, in order to protect people. However, those who take lots of deposits are obviously being pressed by our constituents to return that money, and that may put them in financial distress, but equally our constituents need the money back given their financial circumstances. I accept that the Secretary of State may not have an answer for me now, but will he at least commit to take the issue away and see whether an answer is forthcoming, perhaps with the support of the Treasury?

[Matt Hancock]

Yes, I will get my right hon. Friend an answer from the Department for Business, Energy and Industrial Strategy.

Coronavirus

Debate between Mark Harper and Matt Hancock

Tuesday 3rd March 2020 Commons Chamber

[Mr Mark Harper (Forest of Dean) (Con)]

The Secretary of State will know there are two confirmed cases in Gloucestershire, and I put on record my thanks to the public health professionals who have dealt with those cases in a professional, calm and considered manner.

My specific question is about the action the Department for Work and Pensions will take for those members of the public who, whether because of business downturn or because of self-isolation, have to access the benefits system. Will frontline DWP staff and systems accommodate the fact that self-isolation, as the Secretary of State says, should be treated as an illness and that no inappropriate sanctions should be applied?

[Matt Hancock]

We are absolutely clear that that is the rule, and I frequently talk to the Secretary of State for Work and Pensions about this matter.

Health and Social Care

Debate between Mark Harper and Matt Hancock

Thursday 16th January 2020 Commons Chamber

[Matt Hancock]

The cash boost that we are giving now is bigger. I think today is the anniversary of Prime Minister Tony Blair sitting on the couch of a TV show, talking about increasing funding for the NHS, which was opposed by Gordon Brown, who was Chancellor of the Exchequer at the time. We will not take any lectures.

I am thrilled that the public comprehensively rejected the Labour party’s baseless scaremongering, which was repeated through the election campaign and worried some of the most vulnerable people who rely on our NHS. I lost count of the number of times I had to debunk some politicised nonsense put about by the Opposition across the country because they had nothing positive to say. The hon. Member for Leicester South was at it again yesterday and in his speech. He said that the settlement in the NHS Funding Bill is a cap, although clause 1 states that it is a minimum. Clause 1(1) states:

“In making an allotment to the health service in England for each financial year…the Secretary of State must allot an amount that is at least the amount specified”.

Did the hon. Gentleman even read the Bill? Did he get to clause 1? I am not sure he bothered reading it.

Let us look specifically at the amendment. It calls for reform of social care and for the Government to bring forward a plan, and that is precisely what the Queen’s Speech provides for. It also calls for additional funding for the NHS, which is what we are legislating for. The long-term plan is fully funded by the largest cash injection in the history of the NHS, and I urge Members across the House to support it fully. We can only fund the NHS with a strong economy, and that is exactly what we will do.

[Mr Harper]

The Secretary of State will have heard my earlier exchanges with the shadow Secretary of State, which I hope were helpful. He will be aware that more than half the budget for adult social care in England is spent not on older people but on those of working age, as we try to enable people to be more independent and to work. Will he confirm that the social care plan that he plans to discuss with other parties, and which he will bring forward this year as the Prime Minister committed to do, will cover older people and those of working age, and will probably entail different solutions for those two groups?

[Matt Hancock]

The proposals that we are working on include solutions for the provision of social care for older and retired people as they decline in the later years of their lives, and for people of working age. Part of the point about consensus building is that we must be open to options and look right across the piece. It was a disappointment that the Labour party proposals that came out in the autumn only covered older people and not working-age adults, and that point must be addressed. I hope we can do that in a spirit of cross-party discussion, and that those on the Opposition Front Bench will engage positively with that. We will engage right across the House when trying to bring forward a solution.